Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 30, 2026
Investigational device to be studied in pre-market, randomized pivotal trial
-
Sep 29, 2026
Company recognized for improving healthcare outcomes through technology
-
Sep 16, 2026
A next-generation blade designed to improve efficiency in paranasal sinus surgery
-
Sep 10, 2026
More than 23 procedures performed across seven sites in Germany, the United Kingdom, Italy, and Spain
-
Sep 3, 2026
Following recent U.S. Food and Drug Administration (FDA) labeling approval, European label milestone reinforces Medtronic leadership in advancing aortic care based on clinical evidence supporting the treatment of ruptured abdominal aortic aneurysms (rAAA).